Login to Your Account

Clinic Roundup

Friday, December 7, 2012

• Cytomedix Inc., of Gaithersburg, Md., said it signed an agreement with the National Institutes of Health to collaborate on a Phase II study in patients with intermittent claudication, which is caused by peripheral arterial disease.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription